Picture a world where most life-saving medicines are discovered not in the United States, but in Beijing and Shanghai. Imagine a time when the most advanced biotechnologies—therapies that cure cancer and Alzheimer's, protect us from pandemics and fuel our economy—are controlled not by America, but by our chief global adversary. That is the future we risk drifting into soon if we do not act now to secure and advance American dominance in biotechnology.

Today, America still leads the world in biotechnology. But China is fast closing the gap and is close to overtaking us. Chinese dominance in biotechnology would have dire, even existential, consequences for our economy and our national security. It would leave Americans dependent on an authoritarian rival for critical medicines, giving China

See Full Page